EA201100488A1 - Лиганды, которые обладают специфичностью связывания в отношении dc-sign - Google Patents

Лиганды, которые обладают специфичностью связывания в отношении dc-sign

Info

Publication number
EA201100488A1
EA201100488A1 EA201100488A EA201100488A EA201100488A1 EA 201100488 A1 EA201100488 A1 EA 201100488A1 EA 201100488 A EA201100488 A EA 201100488A EA 201100488 A EA201100488 A EA 201100488A EA 201100488 A1 EA201100488 A1 EA 201100488A1
Authority
EA
Eurasian Patent Office
Prior art keywords
sign
ligands
specific binding
compositions
binding relation
Prior art date
Application number
EA201100488A
Other languages
English (en)
Inventor
Рудольф Мария Де Вильдт
Original Assignee
Домантис Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Домантис Лимитед filed Critical Домантис Лимитед
Publication of EA201100488A1 publication Critical patent/EA201100488A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

В настоящем изобретении предложен единичный вариабельный домен иммуноглобулина против специфического для дендритных клеток ICAM-3-захватывающего неинтегрина (DC-SIGN; CD209). Также описаны полипептиды, лиганды и композиции, содержащие такие единичные вариабельные домены иммуноглобулина против DC-SIGN, вместе с нуклеиновыми кислотами, кодирующими такие иммуноглобулины, а также векторами и клетками-хозяевами для экспрессии. Кроме того, изобретение относится к применениям, препаратам, композициям и устройствам, содержащим такие DC-SIGN-связывающие агенты.
EA201100488A 2008-10-21 2009-10-19 Лиганды, которые обладают специфичностью связывания в отношении dc-sign EA201100488A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10708508P 2008-10-21 2008-10-21
PCT/EP2009/063655 WO2010046337A2 (en) 2008-10-21 2009-10-19 Ligands that have binding specificity for dc-sign

Publications (1)

Publication Number Publication Date
EA201100488A1 true EA201100488A1 (ru) 2011-12-30

Family

ID=42062429

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201100488A EA201100488A1 (ru) 2008-10-21 2009-10-19 Лиганды, которые обладают специфичностью связывания в отношении dc-sign

Country Status (16)

Country Link
US (1) US20110257373A1 (ru)
EP (1) EP2356149A2 (ru)
JP (1) JP2012506237A (ru)
KR (1) KR20110071139A (ru)
CN (1) CN102257009A (ru)
AR (1) AR073905A1 (ru)
AU (1) AU2009306424A1 (ru)
BR (1) BRPI0919714A2 (ru)
CA (1) CA2740856A1 (ru)
EA (1) EA201100488A1 (ru)
IL (1) IL212086A0 (ru)
MX (1) MX2011004244A (ru)
TW (1) TW201019962A (ru)
UY (1) UY32189A (ru)
WO (1) WO2010046337A2 (ru)
ZA (1) ZA201102763B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ592084A (en) * 2008-10-21 2013-01-25 Domantis Ltd Composition comprising a membrane vessicle derived antigen, and an anti-DC-SIGN immunoglobulin single variable domain for targeting dendritic cells
US9481724B2 (en) * 2011-12-19 2016-11-01 The Rockefeller University hDC-sign binding peptides
WO2023028593A2 (en) * 2021-08-27 2023-03-02 University Of Georgia Research Foundation, Inc. Targeted nanoparticles and their uses related to infectious disease

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU665440B2 (en) * 1992-06-05 1996-01-04 Dade Produktions Ag Rabbit single domain antibody and use thereof
WO2004041862A2 (en) * 2002-11-08 2004-05-21 Ablynx N.V. Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
EP1587838B1 (en) * 2003-01-10 2015-04-15 Ablynx N.V. Therapeutic polypeptides, homologues thereof, fragments thereof and their use in modulating platelet-mediated aggregation
EP1627062A1 (en) * 2003-05-14 2006-02-22 Domantis Limited A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire
ES2315664T3 (es) * 2003-06-30 2009-04-01 Domantis Limited Anticuerpos de dominio unico (dab) pegilados.
JP4970035B2 (ja) * 2003-08-21 2012-07-04 リポテック・プロプライエタリー・リミテッド ｉｎｖｉｖｏにおける樹状細胞の標的化
WO2005118642A2 (en) * 2004-06-01 2005-12-15 Domantis Limited Bispecific fusion antibodies with enhanced serum half-life
CN101133084A (zh) * 2004-12-02 2008-02-27 多曼蒂斯有限公司 采用白细胞介素-1ⅰ型受体拮抗剂治疗呼吸道疾病的方法
AU2005311099B2 (en) * 2004-12-02 2012-02-02 Domantis Limited Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY
AU2006224438A1 (en) * 2005-03-18 2006-09-21 Antonio Cassone Antibodies against Candida antigens
EA013878B1 (ru) * 2005-12-06 2010-08-30 Домантис Лимитед Лиганды, имеющие специфичность связывания в отношении рецептора эпидермального фактора роста (egfr) и/или сосудистого эндотелиального фактора роста (vegf), и способы их применения
WO2007066109A1 (en) * 2005-12-06 2007-06-14 Domantis Limited Bispecific ligands with binding specificity to cell surface targets and methods of use therefor
WO2007085815A2 (en) * 2006-01-24 2007-08-02 Domantis Limited Ligands that bind il-4 and/or il-13
AU2007300543A1 (en) * 2006-09-26 2008-04-03 Alexion Pharmaceuticals, Inc. Compositions and methods for enhancing an adjuvant
WO2008070363A2 (en) * 2006-10-31 2008-06-12 Domantis Limited Intrabodies
CN101182539A (zh) * 2007-11-06 2008-05-21 浙江大学 Dc-sign启动子荧光素酶报告质粒的构建方法

Also Published As

Publication number Publication date
TW201019962A (en) 2010-06-01
MX2011004244A (es) 2011-05-25
ZA201102763B (en) 2012-09-26
EP2356149A2 (en) 2011-08-17
UY32189A (es) 2010-05-31
KR20110071139A (ko) 2011-06-28
WO2010046337A3 (en) 2010-07-01
CN102257009A (zh) 2011-11-23
WO2010046337A2 (en) 2010-04-29
JP2012506237A (ja) 2012-03-15
AU2009306424A1 (en) 2010-04-29
IL212086A0 (en) 2011-06-30
CA2740856A1 (en) 2010-04-29
US20110257373A1 (en) 2011-10-20
BRPI0919714A2 (pt) 2015-12-08
AR073905A1 (es) 2010-12-09

Similar Documents

Publication Publication Date Title
EA201491186A1 (ru) Полипептиды химерного фактора viii и их применение
EA201270174A1 (ru) Отдельные связывающиеся вариабельные домены с улучшенными свойствами, направленные против сывороточного альбумина
MY177065A (en) 4-1bb binding molecules
EA201590198A1 (ru) Комплекс фактора viii с xten и белком фактора фон виллебранда и его применение (варианты)
WO2006122825A3 (en) Single domain vhh antibodies against von willebrand factor
AU2013211824A8 (en) Fusion proteins comprising IgG2 hinge domains
MX350962B (es) Metodo para fabricar moleculas heterodimericas de fragmentos cristalizables de anticuerpo, utilizando efectos electrostaticos de direccion.
EA201600338A1 (ru) Биспецифическая связывающая молекула, связывающаяся с vegf и ang2
CO6280541A2 (es) Anticuerpos monoclonales o fragmentos del mismo que se unen al recptor humano ox40
EA201591376A1 (ru) Конструкции антител к cdh19 и cd3
WO2013024059A3 (en) Modified single variable domain antibodies with reduced binding to anti-drug-antibodies
EA201590545A1 (ru) Полипептиды, содержащие fc с измененным гликозилированием и сниженной эффекторной функцией
CL2008000912A1 (es) Proteina insecticida hibrida que comprende dos proteinas cry del bacillus thuringiensis (bt) diferentes; molecula de acido nucleico que comprende dicha proteina; casete de expresion, vector recombinante que comprenden el acido nucleico; celula transg
MX351502B (es) Anticuerpos de union de albumina y fragmentos de union de los mismos.
NZ761636A (en) Antigen binding proteins binding to 5t4 and 4-1bb and related compositions and methods
PH12014501912A1 (en) Cx3cr1-binding polypeptides
EA201592022A1 (ru) Расщепляемый тромбином линкер, содержащий xten, и его применение
MX2020002921A (es) Anticuerpos para claudin6 y métodos para tratar el cáncer.
AU2011353197A8 (en) A cross linking polypeptide comprising an hexameric single chain antibody binding MHC-MAGE complex that induces apoptosis
EA201100488A1 (ru) Лиганды, которые обладают специфичностью связывания в отношении dc-sign
WO2010142551A8 (en) Amino acid sequences directed against receptors to cytokines belonging to the il-17 family
MX2019014400A (es) Inmunoglobulinas que se unen a adamts.
WO2012072731A3 (en) Improved anti-serum albumin binding single variable domains
ATE539152T1 (de) Neue verfahren
WO2009120378A3 (en) Methods for increasing absorption of peptides, peptidomimetics, and other gastrointestinal transport protein substrates